A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists | Zendy

Efstratios M. Κolibianakis | Zendy; A. Schultze-Mosgau | Zendy; Andreas Schröer | Zendy; André Van Steirteghem | Zendy; Paul Devroey | Zendy; K. Diedrich | Zendy; Georg Griesinger | Zendy

Open Access

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

Author(s) -

Efstratios M. Κolibianakis,

A. Schultze-Mosgau,

Andreas Schröer,

André Van Steirteghem,

Paul Devroey,

K. Diedrich,

Georg Griesinger

Publication year - 2005

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dei150

Subject(s) - triptorelin , oocyte , agonist , medicine , gonadotropin releasing hormone , pregnancy rate , ovarian hyperstimulation syndrome , luteal phase , buserelin , andrology , pregnancy , endocrinology , in vitro fertilisation , follicular phase , biology , luteinizing hormone , hormone , embryo , receptor , genetics , microbiology and biotechnology

Eliciting an endogenous LH surge by GnRH-agonist for the induction of final oocyte maturation may be more physiological compared with the administration of HCG. However, the efficacy of this intervention in patients treated for IVF with GnRH antagonists remains to be assessed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research